PV pharm branch, vendor, cage

Active Indefinite Delivery Contract Awarded Last action

Contract number
SPE2DX22D0051
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 48% complete
IDV ceiling
$28,865,568,773.13
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain on December 17, 2022, with a ceiling value of $28.9 billion and a completion date of December 31, 2030. This contract establishes AmerisourceBergen as a primary pharmaceutical vendor for the Defense Health Agency's TRICARE Pharmacy Program, requiring the contractor to replenish and distribute a comprehensive range of pharmaceutical and medical products to multiple TRICARE pharmacy ordering facilities. The contract encompasses brand-name and generic medications, vaccines, specialty pharmaceuticals for conditions including diabetes, neurological disorders, and pain management, as well as medical devices and supplies such as auto-injectors, syringes, vials, and test kits. Pricing is structured using Federal Supply Schedule prices, DAPA (Department of Defense Ammunition and other Supplies Pricing Agreement) rates, or regional DAPA pricing plus the contractor's distribution fee and cost recovery rate.

The underlying solicitation, published as a Special Notice on June 24, 2020, sought industry feedback on the draft Statement of Work for the National Prime Vendor Generation IV contract, which supports readiness and backup pharmaceutical supply to CONUS (Continental United States) pharmacy ordering facilities while integrating with the TRICARE Pharmacy Program 5 contract. The original solicitation contemplated a base period plus one option period not exceeding five years total, with service to a maximum of 12 pharmacy ordering facilities. This competitive, non-set-aside award demonstrates AmerisourceBergen's capability to fulfill extensive federal pharmaceutical procurement requirements and complements the contractor's existing significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $1 billion through December 2026.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 $0
Supplemental Agreement for work within scope P00011 · 4610088532! $0
Supplemental Agreement for work within scope P00010 · 4610088532 ! PV pharm branch, vendor, cage 0U9U0 $0
Supplemental Agreement for work within scope P00009 · 4610088532 ! PV pharm branch, vendor, cage $0
Exercise an Option P00008 $0
Change Order P00007 $0
Supplemental Agreement for work within scope P00006 $0
Change Order P00005 · 4610088532 ! PV pharm branch, vendor, cage 0U9U0 $0
Change Order P00004 $0
Change Order P00003 $0
Change Order P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award 4610088532 ! PV pharm branch, vendor, cage $0
Show all 13

Quick answers

Who was awarded contract SPE2DX22D0051?

SPE2DX22D0051 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 17, 2022.

How much is contract SPE2DX22D0051 worth?

SPE2DX22D0051's own ceiling is $28,865,568,773.

Who can order from contract SPE2DX22D0051?

SPE2DX22D0051 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2DX22D0051 competed?

The extent of competition for SPE2DX22D0051 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV